Generic drug manufacturers in our country point out that the introduction of treatments on the compensation list occurs with ...

Zydus Lifesciences’ subsidiary ZyVet Animal Health has launched FDA-approved generics for urinary incontinence ...

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

AbbVie (ABBV) stock in focus as the company settles with generic drugmakers to resolve litigation related to copycat versions ...

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

Zentiva's operations span the development, production and distribution of medicines in more than 30 countries.

One of the great triumphs of health policy is America’s generic drug market. Nine out of ten U.S. prescriptions are filled with generics. That overwhelming share saves patients and taxpayers hundreds ...

Penn researchers say they will pursue larger-scale studies to continue testing whether hydroxychloroquine and everolimus can ...

The real question is how to re-shore pharmaceutical production while minimizing the costs to patients, economist Tomas J.

The $5.7 billion Indian drug maker is building capacity to tap into the massive opportunity from GLP-1 drugs to open up in ...